• VENERDÌ 17 SETTEMBRE 2021 - S. Roberto Bellarmino

Daewoong Pharmaceutical Announces Camostat Achieving 50% Faster Recovery Time for Mild COVID-19 Patients Over Age of 50 in Topline Results from Phase 2B Clinical Trial

ATTENZIONE
Tutto il materiale presente in questo articolo è coperto da Copyright Adnkronos.com e ne è vietata la riproduzione, anche parziale.


- Improvement of symptoms such as cough and dyspnea in mild patients over age 50 was reported to be as twice as fast and statistically significant in the treatment group (4 days) compared to the placebo control group (9 days).



Macrolibrarsi
Sannioportale.it